Objective-To determine the intracellular mechanisms mediating the angiogenic effects of integrin ␣v␤5 overexpression in circulating angiogenic cells (CACs). Methods and Results-Integrin ␣v␤5 is expressed on angiogenic endothelial cells, and integrin ␣v␤5 activation was shown to improve the reparative functions of endothelial progenitors within the cardiovascular system. CACs were transiently transfected with the full-length cDNA of human integrin ␤5 (CAC-ITGB5) or control-vector (CAC-vector). Integrin ␤5 overexpression was confirmed using flow cytometry, Western blot, and PCR analysis; it enhanced the angiogenic capacities of CACs in vitro (spheroid and Matrigel angiogenesis assay) and stimulated new vessel formation in vivo (murine hind limb ischemia model). Overexpression of ITGB5 resulted in integrin ␣v␤5 phosphorylation and activation of Src kinase and signal transducer and activator of transcription (STAT) 3. Furthermore, elevated mRNA and protein expression of the CXC chemokine CXCL8 and the CC chemokine CCL2 was detected in CAC-ITGB5, and conditioned medium from CAC-ITGB5 enhanced the sprouting of coincubated human endothelial cells in a STAT3-, CXCL8-, and CCL2-dependent manner. Conclusion-Src kinase-mediated activation of STAT3 and subsequent angiogenic gene expression mediate the effects of integrin ␣v␤5 and may be exploited to enhance the paracrine activities of CACs. (Arterioscler Thromb Vasc Biol.
A ngiogenesis is a hallmark of diverse physiological and pathological processes, including wound healing, inflammation, and tumor growth. The formation of new blood vessels from the existing vasculature involves the proliferation, migration, and morphogenesis of endothelial cells in response to growth factors and cytokines; and cross talk between growth factor and integrin receptors, both direct and indirect, via adaptor proteins or nonreceptor protein tyrosine kinases has been shown to modulate angiogenic signaling. 1 In addition to repair mechanisms provided by local cells, endothelial progenitor cells (EPCs) mobilized from the bone marrow into the circulation in response to tissue injury signals have been shown to contribute to neovascularization or reendothelialization after ischemia or endothelial denudation. 2, 3 At least 2 types of EPCs need to be distinguished depending on the isolation protocol and their phenotypic and functional behavior in culture: endothelial colony unit-forming cells (late-outgrowth EPCs) and circulating angiogenic cells (CACs; early-outgrowth EPCs). 4, 5 Although both cell types have been demonstrated to promote endothelial repair, their distinct functional characteristics may explain why EPCs structurally contributed to tissue repair in some studies, 6, 7 whereas other studies 8, 9 could not demonstrate incorporation, but rather secretion of paracrine factors acting on neighboring cells to stimulate proliferation, migration, and angiogenesis.
Vitronectin receptors (ie, the integrins ␣v␤3 and ␣v␤5) are expressed on angiogenic endothelial cells. 10 Regarding their exact function during angiogenic processes, discrepant findings in gene-deleted mice as opposed to data obtained after integrin function blockade have left some uncertainties. [11] [12] [13] [14] Previous findings 15, 16 suggest that upregulation of ␣v␤5 integrins on (early-outgrowth) EPCs may be involved in mediating reendothelialization and neovascularization. Thus, in the present study, we began to analyze the effect of integrin ␤5 overexpression on the angiogenic properties of CACs and to determine the intracellular mechanisms mediating the effects of ␣v␤5 integrin. Because ␣v integrins would form heterodimers with several different integrin ␤ chains (eg, ␤1, ␤3, ␤6, and ␤8) in addition to ␤5, thus precluding a specific analysis, CACs were transfected with human integrin ␤5 (ITGB5) cDNA only. Our findings suggest an important role for the cytoplasmic protein kinase Src in linking ␤5 integrin phosphorylation to signal transducer and activator of transcription (STAT) 3 activation, followed by downstream signal transduction, CXCL8 and CCL2 gene expression, and angiogenesis.
Methods
EPCs were isolated, cultivated, and phenotyped as previously described. 15, 16 Based on the isolation protocol, their proliferative behavior, and surface marker expression profile, cells were characterized as CACs, in accordance with a recently proposed definition. 4, 5 A detailed description of all methods used in the present study is provided in the supplemental materials (available online at http://atvb.ahajournals.org). 
Results

Confirmation of Integrin ␣v␤5 Overexpression in CACs
CACs were isolated from the mononuclear cell fraction of peripheral blood drawn from healthy human volunteers, transfected with human full-length integrin ␤5 cDNA or empty control-vector on day 5, and phenotyped and functionally analyzed 48 hours later. Flow cytometry analysis demonstrated enhanced ␣v␤5 integrin surface expression ( Figure 1A) ; and elevated levels of ␤5 mRNA and protein expression were confirmed using RT-PCR ( Figure 1B ) and Western blot analysis ( Figure 1C) , respectively. As shown in Figure 1D , surface expression of integrin ␣v, ␣v␤3, and the ␣v integrin chain binding partner ␤1 was also significantly upregulated in CAC-ITGB5, whereas the expression of integrin ␤2 was unchanged. Furthermore, integrin ␤5 tyrosine phosphorylation was significantly enhanced in CAC-ITGB5 ( Figure 1E ), resulting in enhanced adhesion on and migration toward the ␣v␤5 ligand vitronectin ( Figure 1F and G, respectively); both could be prevented by integrin ␣v␤5-neutralizing antibodies.
Integrin ␤5 Overexpression Enhances the Angiogenic Properties of CACs In Vitro and In Vivo
To examine the effect of integrin ␤5 overexpression on the angiogenic properties of CACs, we first used 2 in vitro angiogenesis assays. By using the 3D spheroid assay, we found that integrin ␤5 overexpression enhanced the number of CACs migrating along outgrowing human umbilical vein endothelial cell (HUVEC) sprouts (Figure 2A and B) . Interestingly, spheroids consisting of HUVECs and CAC-ITGB5 formed more and longer sprouts than those composed of HUVEC and CAC-vector ( Figure 2C ). In the Matrigel angiogenesis assay, integrin ␤5 overexpression increased the number of CACs adherent to networklike structures provided by HUVECs ( Figure 2D ). More important, the effects of integrin ␤5 overexpression could be reversed by preincubation of CACs with ␣v␤5 integrinneutralizing antibodies in both assays.
Next, the effects of integrin ␤5 overexpression on CACmediated angiogenesis were tested in vivo using the mouse model of unilateral hind limb ischemia. ITGB5-or vectortransfected CACs were injected into athymic nude mice after induction of ischemia by ligation and excision of the right femoral artery. Immunohistological analysis of lower hind limb muscle tissues revealed more CD31-immunopositive capillary endothelial cells ( Figure 2E ) and smooth muscle cell alpha-actin (SMA)-immunopositive arterioles ( Figure 2F ) per square millimeter in mice that had received integrin ␤5-overexpressing CACs; many red-fluorescent CACs were detected after injection of DsRed-ITGB5-transfected human CACs, frequently colocalizing with CD31-positive murine endothelial cells ( Figure 2G ; higher magnification images are shown in supplemental Figure I ). Serial laser Doppler imaging confirmed significantly improved tissue perfusion on day 14 after ischemic induction in footpads of mice treated with CAC-ITGB5 compared with those treated with vectortransfected CACs or with PBS alone (no CACs) ( Figure 2H ).
Effects of Integrin ␤5 Overexpression on Angiogenesis Involve Paracrine Mechanisms
Because findings in the spheroid assay ( Figure 2C ) suggested that paracrine actions may be involved in mediating the angio- genic effects of ITGB5 overexpression in CACs, we examined the ability of conditioned medium (CdM) alone to stimulate sprouting of mature endothelial cells. HUVEC spheroids revealed a higher cumulative sprout length if they were incubated with CdM from CAC-ITGB5 compared with incubation with CdM from CAC-vector ( Figure 3A) . Screening of CdM using cytokine antibody arrays revealed markedly elevated levels of the chemotactic and angiogenic cytokines CXCL8 and CCL2 in CdM from CAC-ITGB5 ( Figure 3B ); these findings were confirmed using quantitative ELISA ( Figure 3C ). PCR analysis demonstrated significantly elevated gene transcription of CXCL8 and CCL2 in CAC-ITGB5 compared with vectortransfected cells ( Figure 3D ).
Integrin ␤5 Overexpression Results in Activation of the Transcription Factor STAT3
Because expression of the previously mentioned chemokines is controlled by the transcription factor STAT3, we examined whether ITGB5 overexpression affects STAT3 activation. Western blot analysis revealed increased tyrosine phosphory- lation of STAT3 in ITGB5-compared with vector-transfected CACs ( Figure 4A ), and similar findings were obtained after flow cytometry detection of intracellular tyrosine-phosphorylated STAT3 ( Figure 4B ). No changes in the phosphorylation of Janus kinase-2 (Jak2), part of the canonical Jak2-STAT3 pathway downstream of cytokine receptors, could be observed. After tyrosine phosphorylation, activated STATs form dimers and translocate to the nucleus, where they bind to specific promotor regions and influence gene transcription. Consistently, immunofluorescence revealed a predominant nuclear localization of phosphorylated STAT3 in CAC-ITGB5, whereas most of phosphorylated STAT3 in vectortransfected CACs was found within the cytoplasm ( Figure  4C ). Cell fractionation, followed by Western blot analysis, confirmed the increased nuclear localization of phosphorylated STAT3 in CAC-ITGB5 ( Figure 4D ).
Increased STAT3 Tyrosine Phosphorylation Induced by Integrin ␤5 Overexpression Is Mediated by Src Kinase
Next, we examined possible signal transducers upstream of activated STAT3 in ITGB5-overexpressing CACs. These studies showed increased phosphorylation of the nonreceptor protein tyrosine kinase Src, known to be involved in integrin-mediated outside-in signal transduction, 17 in CAC-ITGB5 ( Figure 5A and B). Integrin ␣v␤5 function-blocking antibodies reduced the amount of phosphorylated Src and STAT3 in CAC-ITGB5 ( Figure 5A and B), and inhibition of Src kinase with 4-amino- Figure 5C and D). The amount of STAT3 that could be coimmunoprecipitated together with Src kinase was reduced in CAC-ITGB5 compared with vector-transfected CACs, and integrin ␣v␤5-neutralizing antibodies restored Src kinase-STAT3 complex formation ( Figure 5E ). On the other hand, pretreatment of CAC-ITGB5 with PP2 completely abolished coimmunoprecipitation of Src-STAT3, supporting a role for Src kinase in STAT3 activation.
5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyramidine (PP2) (at least partially) reduced STAT3 phosphorylation (
Angiogenic Effects of ITGB5 Overexpression Can Be Abolished by Inhibition of STAT3
To confirm a role for STAT3 activation in mediating the effects of integrin ␤5 overexpression on CAC angiogenesis, we preincubated CAC-ITGB5 with a cell-permeable STAT3 inhibitor, specifically targeting the STAT3-sulfhydryl 2 domain and blocking STAT3-dependent gene transcription. 18 First, immunofluorescence demonstrated that the amount of nuclear phosphorylated STAT3 was reduced after treatment of CAC-ITGB5 with anti-STAT3 ( Figure 6A ). Functional analysis revealed that inhibition of STAT3 reduced the effects of integrin ␤5 overexpression on CAC migration ( Figure 6B ) and also completely abolished its effects in promoting their in vitro angiogenic capacities ( Figure 6C ). Moreover, STAT3 inhibition prevented the effects of CdM from CAC-ITGB5 on HUVEC sprouting (Figure 6D ), reduced the levels of CXCL8 and CCL2 in the CdM from ITGB5-transfected CACs ( Figure  6E) , and abolished the increased mRNA expression of CXCL8 and CCL2 ( Figure 6F ). Finally, neutralization of either CXCL8 or CCL2 completely abolished the sprouting of HUVEC cells after coincubation with CdM from ITGB5-transfected CACs (Figure 6G ), underlining a causal role of both chemokines as mediators of the paracrine and proangiogenic action of integrin ␤5 in CACs.
Discussion
The aim of the present study was to identify mechanisms and signal transduction steps mediating the effects of integrin ␣v␤5 overexpression on the angiogenic properties of CACs. We show that overexpression of integrin ␣v␤5 did the following: (1) enhanced the capacity of CACs to adhere to endothelial cell networks in vitro and to promote new blood vessel formation in vivo, (2) increased the phosphorylation of integrin ␣v␤5 and Src kinase, (3) resulted in STAT3 activation and nuclear translocation, and (4) increased mRNA and protein expression and increased secretion of the angiogenic chemokines CXCL8 and CCL2. More important, the angiogenic effects of ␣v␤5 overexpression could be abolished by integrin ␣v␤5 function-blocking antibodies and inhibition of STAT3 and neutralizing antibodies against CXCL8 and CCL2, respectively. ␣v integrins are expressed on hematopoetic and endothelial cells and upregulated during angiogenesis and vascular remodeling. 10, 19 Although blockade of ␣v␤3 or ␣v␤5 using monoclonal antibodies, low-molecular-weight inhibitors, or small interfering RNA prevented blood vessel formation in vitro and in vivo, 12, 20, 21 their role (particularly ␣v␤5) in angiogenic processes remains incompletely understood. For example, integrin ␣v-knockout mice show normal vascular patterning and intact endothelial cell functions, but die within the first day after birth as the result of intracranial hemorrhaging from distended vessels. 11 On the other hand, endothelial cell-specific deletion of ␣v integrins had no detectable effect on cerebral blood vessel development. 22 Furthermore, ␤3-and/or ␤5-knockout mice develop normally, but exhibit pathological angiogenesis later in life. 14 Mice with genetic deletion of integrin ␤5 alone revealed no specific vascular phenotype, 13 but did not respond to vascular endothelial growth factor (VEGF) with increased vascular permeability. 23 Possible explanations for these inconclusive findings include overlapping functions, compensatory upregulation, or transdominant inhibition of other integrins. 24 It was recently shown that preincubation of (early-outgrowth) EPCs with the adipokine leptin upregulated ␣v␤5 integrin expression, promoted their adhesion to the integrin ␣v␤5 ligand vitronectin, and enhanced reendothelialization after vascular injury in an ␣v␤5 integrin-specific manner, thus reducing neointima formation and luminal narrowing. 15 Furthermore, the angiogenic effects of leptin on CACs involved activation of integrin ␣v␤5 and downstream signaling transduction pathways. 16 Interestingly, the beneficial effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) on reendothelialization after carotid balloon injury also involved upregulation of integrin ␣v␤5 on EPCs, 25 whereas oxidized low-density lipoprotein was shown to impair EPC function by downregulating integrin ␣v␤5. 26 The results of the present study confirm and extend those previous findings by showing that ex vivo stimulation of CACs with 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors and intake of statin medication both significantly enhanced the expression of integrin ␣v␤5 on the surface of human CACs (supplemental Figure IIA and B) . Taken together, these findings suggest that integrin ␣v␤5 expression on CACs may be important for mediating some of their beneficial functions within the cardiovascular system; the results led us to examine whether and how overexpression of integrin ␤5 alone (ie, without prior stimulation of cells with, for example, leptin or statins) may positively modulate their angiogenic properties. Flow cytometry analysis consistently confirmed a moderate overexpression of ␣v␤5 integrins on ITGB5-transfected CACs and also revealed concomitant upregulation of other integrin chains, in particular of those known to form heterodimers with integrin ␤5 (ie, ␣v) or ␣v (ie, ␤1 and ␤3), whereas ␤2 integrin surface expression was unaltered. The mechanisms underlying this phenomenon remain unexplained and did not involve increased mRNA expression (data not shown). Although we cannot exclude the possibility that some of the observed effects were the result of upregulation of integrin heterodimers other than ␣v␤5, neutralizing antibodies specific to ␣v␤5 integrin completely blocked CAC adhesion, migration, and angiogenesis in vitro; and prevented signal transduction events, such as Src kinase and STAT3 phosphorylation, in CAC-ITGB5.
Integrins do not possess intrinsic enzymatic activity, and signaling occurs through interaction with adaptor molecules and protein tyrosine kinases. 27 In this regard, cytoplasmic tyrosine kinases of the Src family are important outside-in signaling intermediates 28 and pivotal in the regulation of integrindependent processes, such as migration, proliferation, and angiogenesis. 29 Cross talk between VEGF receptor 2 and integrin ␣v␤5, followed by Src kinase activation, mediated at least some of the angiogenic effects of VEGF on endothelial cells. 19, 21 Consistently, we found integrin ␤5 overexpression to be associated with elevated levels of basal Src kinase phosphorylation.
Src kinase is a known activator of the mitogen-activated protein kinase pathway 30 and also of the latent transcription factor STAT3. 31, 32 Although STAT3 target genes include potent regulators of cell proliferation, survival, or angiogenesis, only a few studies have examined STAT3 activation downstream of integrins. For example, ␣2␤1 integrins modulated collageninduced cell migration through tyrosine phosphorylation of STAT1 and STAT3. 33 Moreover, ␣5 integrins, Src kinase, and STAT3-induced VEGF expression were reported to mediate the angiogenic effects of tetraspan TM4SF5. 34 Extending those studies, we show that integrin ␣v␤5 overexpression results in STAT3 phosphorylation, followed by nuclear translocation and upregulation of STAT3-dependent angiogenic gene expression. Increased STAT3 tyrosine phosphorylation was detected at position 705, required for STAT3 dimerization and DNA binding. Consistently, nuclear translocation of phosphorylated STAT3, the angiogenic potency of CdM, and the expression and secretion of CXCL8 and CCL2 were markedly reduced after STAT3 inhibition. On the other hand, integrin ␣v␤5 surface expression and adhesion of CAC-ITGB5 to vitronectin were not altered after STAT3 inhibition (data not shown), suggesting that additional pathways participate in mediating the angiogenic effects of integrin ␣v␤5 in CACs. We could further show that Src coimmunoprecipitated with STAT3 and that STAT3 phosphorylation and nuclear translocation were significantly reduced in the presence of a specific Src kinase inhibitor. In addition to direct binding, 31 other possible mechanisms of STAT3 activation via Src kinase may involve small G proteins, such as Rac1 GTPase, 35 although this possibility was not further explored in the present study.
Regarding the potential target genes of STAT3 transcriptional activation, ITGB5-transfected CACs exhibited elevated CXCL8 and CCL2 mRNA and protein expression, resulting in increased secretion of these potent angiogenic chemokines into the CdM. CXCL8 promotes endothelial cell survival, proliferation, and angiogenesis; 36 and increases the homing of intravenously infused CD34-positive progenitor cells into ischemic myocardium. 37 CCL2 is involved in endothelial cell chemotaxis, tube formation, and angiogenesis. 38 -40 Local upregulation of CCL2 after hind limb ischemia facilitates inflammatory monocyte recruitment and angiogenesis, 41 whereas blockade of CCL2 or deficiency of its receptor CCR2 diminished blood flow recovery after hind limb ischemia. 42, 43 In line with these findings, immunofluorescence analysis suggested increased levels of CCL2 antigen in ischemic hind limbs of mice that received CAC-ITGB5 after injury (supplemental Figure III) . Similar to endothelial cells, 40 CACs expressed CCR2 and CXCR2 (data not shown), the receptors for CCL2 and CXCL8, respectively, suggesting that increased secretion of chemokines from CAC-ITGB5 could potentiate the angiogenic phenotype of neighboring endothelial (progenitor) cells in an autocrine and paracrine manner. Furthermore, inhibition of STAT3 with subsequent downregulation of CXCL8 and CCL2 secretion into the CdM, or addition of neutralizing antibodies against both chemokines, significantly reduced its paracrine effects on HUVEC sprouting. Notably, expression of VEGF, an important STAT3-regulated gene, was not altered. In fact, VEGF protein levels in CdM were less than the detection level of a commercial ELISA in both ITGB5-and vector-transfected CACs, suggesting that Src-mediated STAT3 activation and angiogenesis did not involve VEGF in our cell model. In summary, our findings suggest that ITGB5 overexpression promotes the angiogenic properties of CACs via Src kinasemediated activation of STAT3, followed by increased transcription of angiogenic chemokines (ie, CXCL8 and CCL2) and potentiation of their paracrine activities. In addition to providing new insights into specific mechanisms mediating the effects of ␣v␤5 integrins during angiogenic processes, our findings also demonstrate that modulation of integrin expression is feasible and potentially useful to modify and improve the functional (paracrine) capacities of CACs.
